Brookstone Hires Head of Life Sciences Investments

Nov 11 2005 | 8:22pm ET

Scott Moonly has been appointed v.p. of life science investments for Brookstone Capital, which specializes in alternative investment opportunities.

Moonly, who joins the firm from L.E.K. Consulting, will be responsible for identifying life science investment opportunities and performing due diligence on both private and public companies. He holds a Ph.D. in biomedical engineering.

In addition to working at L.E.K. Consulting, Moonly has served as an investment analyst with the Merrill Lynch Healthcare Group where he provided financial and strategic analysis for biotechnology and medical device companies. Brookstone has offices in Costa Mesa, Calif. and Las Vegas.

In Depth

Related-Company Fees: Normal Industry Practice or Conflicted Compensation?

Nov 11 2015 | 4:23pm ET

Regulatory agencies as well as investors are increasingly exploring whether certain...


Ferrari Roars in Wall Street Debut

Oct 21 2015 | 4:28pm ET

Shares of supercar maker Ferrari jumped as much as 15 percent to a high of nearly...

Guest Contributor

Private Debt - What is the Opportunity?

Nov 11 2015 | 3:28pm ET

In this contributed article, Rob Allard, founding partner of Firebreak Capital...


Editor's Note

    Oct 21 2015 | 10:41am ET

    One of the most unique charity benefits in the hedge fund industry, A Leg To Stand On's (ALTSO's) Hedge Fund Rocktoberfest - NYC, raised nearly $500,000 last Thursday thanks to the generous support of major sponsors and nearly 1,400 attendees from the Tri-State finance, business and hedge fund communities. Read more…